Job Search Results - Biospace
Get Our FREE Industry eNewsletter


Refine Job Search:

Clear All Selections
Selected Employer
AbbVie Stemcentrx
Location (9)
Employers (9)
Area of Expertise (0)
Posted Date (9)
Position Type (9)
Required Education (9)

Clear All Selections

Your search returned 9 jobs



6/23/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/23/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/23/2017
AbbVie Stemcentrx
South San Francisco, CA

Position Description:Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/20/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta™, and Empliciti™ — and a pipeline containing multiple promising new molecules that are being studied...

6/20/2017
AbbVie Stemcentrx
San Francisco, CA

Oncology is a keytherapeutic area for AbbVie, with a portfolio consisting of three marketedproducts — Imbruvica, Venclexta, and Empliciti — and a pipeline containingmultiple promising new molecules that are being studied in nearly 200...

6/8/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...

6/8/2017
AbbVie Stemcentrx
South San Francisco, CA

Oncology is a key therapeutic area for AbbVie, with a portfolio consisting of three marketed products — Imbruvica, Venclexta, and Empliciti — and a pipeline containing multiple promising new molecules that are being studied in nearly 200...